Clinical trial Recruiting at 1 site Interventional Ages 40 to 85

Evaluating masseter muscle thickness after nerve treatment for trigeminal neuralgia

Official title: Change of the Masseter Muscle Thickness Measured by Ultrasonography After Gasser Ganglion Radiofrequency Thermocoagulation Treatment

Run by Başakşehir Çam & Sakura City Hospital · NCT06278194 · Data updated 2026-11-12

This study is testing whether a specific nerve treatment for trigeminal neuralgia can change the thickness of the masseter muscle in patients who haven't found relief from other medications.

Quick facts

Study typeInterventional
Ages40 Years to 85 Years
SexAll
Enrollment30 (estimated)
SponsorBaşakşehir Çam & Sakura City Hospital
Government
Locations1 site (Istanbul, Başakşehir)
StatusRecruiting
StartedMarch 15, 2024
Main results expectedJuly 15, 2025
Study endsOctober 15, 2025
Registry record updatedMarch 5, 2025
Trial IDNCT06278194 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with trigeminal neuralgia who have not responded to medical therapy for at least three months and are planning to undergo radiofrequency thermocoagulation.

Probably not a fit

Patients with coagulation disorders, pregnancy, or those who refuse to participate will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of Gasserian ganglion radiofrequency thermocoagulation on the masseter muscle thickness in patients suffering from trigeminal neuralgia. The procedure aims to alleviate pain by ablating the affected trigeminal nerve branch, which may also impact the masseter muscle due to its innervation. Patients who have not responded to medical therapy for at least three months and are scheduled for this treatment will undergo ultrasound measurements to assess changes in muscle thickness. The study seeks to understand the potential functional effects of the procedure on the masseter muscle.

Why it matters

Potential benefit: If successful, this study could provide insights into the functional impact of nerve ablation on muscle health, potentially improving patient outcomes in trigeminal neuralgia treatment.

How similar studies have gone: While there have been studies on radiofrequency treatments for trigeminal neuralgia, the specific focus on masseter muscle thickness is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pain refractory to medical therapy for at least 3 months
* Planning radiofrequency thermocoagulation of gasserian ganglion
* Accept ultrasound measurements to be performed

Exclusion Criteria:

* Refused to participate in the study
* Not attending follow-ups regularly
* Coagulation disorder
* Pregnancy
* Localized or systemic infection

Where it's running

  • Başakşehir Çam and Sakura City Hospital
    Istanbul, Başakşehir, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Tuba Tanyel Saraçoğlu, MD — Başakşehir Çam & Sakura City Hospital
  • Study coordinator: Burak Erken, MD
  • Email: burak_erken@hotmail.com
  • Phone: +0902129096000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.